Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 791-800 of 2862 for cancer

Edit search filters
  1. A Study To Determine The Best Individualized Cancer Therapy Using Circulating Tumor DNA (CtDNA) In Patients With GI, CNS, And Thoracic Cancers.

    Jacksonville, FL

  2. A Study To Evaluate Effectiveness And Safety Of MBG453 In Combination With Azacitidine In Subjects With Intermediate, High Or Very High Risk Myelodysplastic Syndrome (MDS), Or Chronic Myelomonocytic Leukemia-2 (CMML-2)

    Jacksonville, FL

  3. STIMULUS MDS-US : Sabatolimab Added To HMA In Higher Risk MDS

    Scottsdale/Phoenix, AZ

  4. Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma

    Rochester, MN

  5. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd For Newly Diagnosed Multiple Myeloma

    Rochester, MN

  6. NBTXR3 With Or Without Cetuximab LA-HNSCC

    Jacksonville, FL

  7. TransCon (TC) TLR7/​8 Agonist, TC IL-2 Β/​γ, Pembrolizumab Prior To Surgery For Advanced Head And Neck Squamous Cell Carcinoma (BelieveIT-201)

    Rochester, MN

  8. A Study Of MT-0169 In Participants With Relapsed Or Refractory Multiple Myeloma Or Non-Hodgkin Lymphoma

    Jacksonville, FL, Rochester, MN

  9. A Study To Compare Treatment With The Drug Selumetinib Alone Versus Selumetinib And Vinblastine In Patients With Recurrent Or Progressive Low-Grade Glioma

    Rochester, MN

  10. A Study To Evaluate Duloxetine To Prevent Oxaliplatin-Induced Peripheral Neuropathy In Patients With Stage II-III Colorectal Cancer

    Eau Claire, WI, Mankato, MN, Rochester, MN

.

Mayo Clinic Footer